formulation as blue-coloured, sweet-tasting tablets, and in the fact that it is prescribed for migraine, a relatively non-serious disease. Dixarit is probably regarded as a non-dangerous drug, being stored in places accessible to children, while, by contrast, the antihypertensive Catapres is treated with appropriate respect. We hope that this article will alert doctors prescribing Dixarit so that they can issue appropriate warnings to parents to keep this drug out of the reach of young children.
When the size of this problem became known, the manufacturers alerted pharmacists through a letter published in the Pharmaceutical Journal,5 and, more recently, a warning has been incorporated in the label on the standard package for Dixarit. As yet, we have detected no decrease in the rate of new cases, possibly because the new labels did not reach all retailers until late 1977. Probably, however, further measures will be needed, and safety packaging is being considered.
We thank those doctors who replied to our questionnaire and thus made possible this survey. We are also grateful to Dr J W Bell and Dr D Segal of Boehringer Ingelheim Ltd Bracknell, UK for their advice and co-operation.
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Case report
The patient was a 31-year-old man, who one week after the onset of non-productive cough, mild fever, and tiredness developed coarse muscle twitching in his fingers. Within one week the twitches had affected several other muscles in the fingers and toes, and he also complained of paraesthesiae in the thenar eminences and mild muscle pains in the hands and feet. His respiratory symptoms subsided after two weeks and the mild fever after three weeks, although muscle twitches persisted for four months.
No abnormal signs whatsoever were found on neurological examination. During the first three weeks after the onset of the disease the blood sedimentation rate was 2-4 mm in the first hour, and the blood leucocyte count 3-4-3-8 x 109/1. There was an insignificant rise in the serum antibody titre of adenoviruses (1/16-1/64) but no other changes in the tested viral antibody titres. The serum electrolytes and transaminase concentrations were normal. Three and four weeks after the start of the disease the serum creatine kinase concentrations were 140 and 41 U/l (at 37'°) respectively. Two months from the onset the blood sedimentation rate was 2 mm in first hour, and the blood leucocyte count 7-6 x 109/1. The ECG and chest x-ray appearances were normal.
Electromyographic findings-The first EMG (taken three weeks after the initial symptoms) was abnormal. The proximal muscles of the arms, predominantly both the biceps, showed insertion activity of prolonged duration and abundant abnormal spontaneous activity as fibrillation potentials and positive sharp waves. Bizarre high-frequency potentials were also present. The motor unit action potentials were normal. A normal interference pattern was detectable with maximal effort. The distal muscles of the arms showed less spontaneous activity, and in the legs only the extensor digitorum brevis showed a few fibrillation potentials. The motor conduction velocities in the median and peroneal nerves were normal, and no fasciculation potentials were found. On repeat EMG examination one month later the pathological findings were fewer: prolonged insertion activity persisted, but spontaneous activity had diminished appreciably. The 
Patients, methods, and results
A total of 129 patients in the Manchester region (67 men, 62 women; mean (±1 SD) age 59±12, weight 62±13 kg, creatinine clearance 60 ± 23 ml/min) receiving maintenance digoxin were studied. Of these, 110 were outpatients and 19 were acute medical admissions. The daily dose (0-27 4 0 11 mg) had been selected previously by a general practitioner or a hospital doctor. We prescribed this as Lanoxin (Wellcome Medical Division Ltd, UK and Ireland Region), to be taken at 1000 and made every effort to encourage compliance. After allowing three weeks to attain "steady state" conditions blood samples for digoxin radioimmunoassay were taken on an average of four visits per patient. Results were expressed as estimated mean steady state concentration.1
The above results were compared with those expected had alternative prescribing methods been used. The alternatives considered were a fixed daily dose of 0-25 mg (method A); a one-compartment model2 (method B), whose predictive value ranked higher than that of other pharmacokinetic models studied'; and the score shown in the figure (method C). The expected concentrations were calculated on the assumption that a proportionalrelationship exists between the dose given to an individual and the digoxin concentration he achieves. Excluded from the comparison were five patients who had not been receiving Lanoxin and ten who were found to be intolerant of digoxin at serum concentrations below 1-28 nmol/l (1 00 jtg/l).
The mean serum digoxin concentration achieved by intuitive dosing (1 94 nmol/l (1 5 fLg/l) ) was similar to that expected for method A (2 05 nmol/l (1-6 Ag/l) ), method B (1 73 nmol/l (1 4 Ktg/l)), and method C (1 78 nmol/l (1 4 lg/l)). The variance in the logarithm of the concentrations achieved, 4 62 x 10-2 (a log,0 transformation being used to approach a normal distribution), was not different (P>0 7) from that expected using A, 4-33 x l0-2, but differed (P< 0-0001) from that expected using B, 2-38 x 10-2, or C, 1 61 x 10-2 (Pitman's test for comparison of correlated variances).3 Expressing the findings in practical terms, we found that 552', of 114 patients given an intuitive dose achieved concentrations within the desired range, 1-28 to 2 56 nmol/l (1 00 to 2 00 ,ug/l), as compared with an expected 52 6 0,, using method A, 59 7 "I using B, and 76-3 UO using C. Methods B and C would have the additional advantage of fewer patients exceeding this range (method B 11-4 00 and C 7-9°/o as against intuitive dosing 21-1 %O and A 202).
Start with a score of zero
The Total score for the patient A score for prescribing digoxin. This was derivedt from data on the 129 patients described
Comment
We have presumed that no doctor intended to exceed a mean steady state serum digoxin concentration of 2 56 nmol/l (2 sLg/l).4 If heart failure or atrial fibrillation remains uncontrolled at this concentration, a diuretic in the first case or a beta-blocker in the second should be added rather than risk cardiotoxicity by increasing the dose of digoxin. Concentrations below 1 28 nmol/l (1 Lg/l) may be beneficial in heart failure and are indicated in those with slow heart rates or symptoms of toxicity at higher concentrations.5 Such patients were excluded from the comparison.
Our results show that doctors with access to patients and their case records were unable to select a dose to give a concentration between 1 28 and 2 56 nmol/l (1-2 [kg/l) any more frequently than if they had simply prescribed 0 25 mg daily to all. The relative value of a conventional pharmacokinetic model in prescribing digoxin and the potential of an empirically derived score are shown. A multicentre trial to evaluate the score in other groups of patients is in progress. SMD 
Patients and mangement
Three patients were referred within a week of open heart surgery. Each had an infraclavicular subclavian venous catheter inserted preoperatively. Two patients had catheters inserted after major abdominal surgery. A standard approach between the clavicle and the first rib was employed in each case. A needle catheter intravenous placement unit* was used in which, after percutaneous insertion of a 14 gauge needle into the vein, a polyethylene catheter was passed through the needle which was then withdrawn leaving the catheter in situ. At the time of removal some three to ten days later the catheters had fractured and either embolised (2) or remained fixed in the subclavian vein (3).
A Seldinger puncture of the femoral vein was performed under local anaesthetic. The venotomy was dilated through a 8 mm skin incision with a 9F gauge dilator. A 9F gauge grey Kifa cathetert (l10 cm long, internal diameter 2 80 mm) was then advanced under fluoroscopic control over a Teflon guide wire to the inferior vena cava. The catheter was manufactured without a tapered tip. A 260 cm long spring guide wire: (0-635 mm diameter) was then doubled over and preshaped so that on insertion through the distal end of the catheter a snare would unfold2 3 (figure). The snare was then manipulated over the distal catheter fragment and drawn tight. The Kifa catheter, snare, and catheter fragment were then withdrawn as an entity through the puncture site and pressure applied for ten minutes. All fragments were easily removed with less than 15 minutes of snare manipulation required.
Kifa catheter and snare assembly.
Comment
Polyethylene catheter insertion through a hollow needle carries the risk of severing the catheter at time of insertion. Often the catheter is just "scored" and after lying in the blood for a few days it becomes brittle and is likely to fracture on withdrawal. Catheter fracture is even more likely using a hollow needle introducer via the infraclavicular approach as the catheter makes a sharp bend at the point of entry to the subclavian vein.5
Many cases of catheter embolism have been followed with no complication but mortality rates up to 40% have been reported for unremoved emboli, especially in ill patients. Early deaths are related to arrhythmias, especially with right ventricular emboli. Thrombosis, clot embolism, cardiovascular perforation, and infection are iess frequent. The high-risk sites for embolic fragments are the right *Bard I-Cath, Bard International Ltd, Sunderland, England. tKifa, Stockholm, Sweden. tWilliam Cook, Denmark. 
